Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease.
Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn's disease, affect several million individuals worldwide. These diseases are heterogeneous at the clinical, immunological and genetic levels and result from complex host and environmental interactions. Investigating drug...
Saved in:
| Main Authors: | Laura-Jayne Gardiner, Anna Paola Carrieri, Karen Bingham, Graeme Macluskie, David Bunton, Marian McNeil, Edward O Pyzer-Knapp |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0263248&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of pharmacogenomics and bioinformatics to exemplify the utility of human ex vivo organoculture models in the field of precision medicine.
by: Karen Cowan, et al.
Published: (2019-01-01) -
Translating “AI for omics” into precision therapy
by: Qi Liu
Published: (2024-09-01) -
Explainable deep learning for stratified medicine in inflammatory bowel disease
by: Nora Verplaetse, et al.
Published: (2025-07-01) -
Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes
by: Jielin Song, et al.
Published: (2025-03-01) -
Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease
by: Consuelo Sauceda, et al.
Published: (2022-12-01)